Clearance of psoriasis with low dose cyclosporin.
作者信息
Griffiths C E, Powles A V, Leonard J N, Fry L, Baker B S, Valdimarsson H
出版信息
Br Med J (Clin Res Ed). 1986 Sep 20;293(6549):731-2. doi: 10.1136/bmj.293.6549.731.
Abstract
摘要
相似文献
1
Clearance of psoriasis with low dose cyclosporin.低剂量环孢素清除银屑病
Br Med J (Clin Res Ed). 1986 Sep 20;293(6549):731-2. doi: 10.1136/bmj.293.6549.731.
2
Long-term cyclosporin for psoriasis.长期使用环孢素治疗银屑病。
Acta Derm Venereol Suppl (Stockh). 1989;146:138-9.
3
Long-term treatment of severe psoriasis with low-dose cyclosporin: (2.5 mg/kg/day to 5 mg/kg/day).低剂量环孢素（2.5毫克/千克/天至5毫克/千克/天）长期治疗重度银屑病。
Acta Derm Venereol Suppl (Stockh). 1989;146:147.
4
Three long-term regimens with cyclosporin for psoriasis vulgaris.三种治疗寻常型银屑病的环孢素长期治疗方案。
Acta Derm Venereol Suppl (Stockh). 1989;146:171-5.
5
Use of cyclosporin in psoriasis.环孢素在银屑病中的应用。
Lancet. 1989;2(8678-8679):1500-2. doi: 10.1016/s0140-6736(89)92941-3.
6
Long-term cyclosporin for psoriasis.长期使用环孢素治疗银屑病。
Br J Dermatol. 1989 Feb;120(2):253-60. doi: 10.1111/j.1365-2133.1989.tb07790.x.
7
Cyclosporin in erythrodermic psoriasis.环孢素治疗红皮病型银屑病。
Acta Derm Venereol Suppl (Stockh). 1989;146:140-1.
8
Long-term treatment of psoriasis with cyclosporin A--side-effects, minimal effective dose and cyclosporin blood levels.环孢素A对银屑病的长期治疗——副作用、最小有效剂量及环孢素血药浓度
Clin Exp Dermatol. 1991 Jan;16(1):8-10. doi: 10.1111/j.1365-2230.1991.tb00283.x.
9
Short-term use of cyclosporin A in severe psoriasis.环孢素A在重度银屑病中的短期应用。
Br J Dermatol. 1986 May;114(5):615-20. doi: 10.1111/j.1365-2133.1986.tb04070.x.
10
Cyclosporin treatment of psoriasis.环孢素治疗银屑病。
Br J Hosp Med. 1991 Sep;46(3):185.
引用本文的文献
1
Significance of cuproptosis- related genes in the diagnosis and classification of psoriasis.铜死亡相关基因在银屑病诊断和分类中的意义
Front Mol Biosci. 2023 Apr 7;10:1115091. doi: 10.3389/fmolb.2023.1115091. eCollection 2023.
2
Understanding psoriasis: the development of the immune pathogenesis.了解银屑病：免疫发病机制的发展。
Clin Exp Dermatol. 2022 Nov;47(11):2072-2073. doi: 10.1111/ced.15360. Epub 2022 Aug 30.
3
The biological basis of disease recurrence in psoriasis: a historical perspective and current models.银屑病复发的生物学基础：历史视角与当前模型。
Br J Dermatol. 2022 May;186(5):773-781. doi: 10.1111/bjd.20963.
4
Psoriasis and Treatment: Past, Present and Future Aspects.银屑病及其治疗：过去、现在和未来的各个方面。
Acta Derm Venereol. 2020 Jan 30;100(3):adv00032. doi: 10.2340/00015555-3386.
5
Psoriasis: Past, Present, and Future.银屑病：过去、现在与未来。
J Invest Dermatol. 2019 Nov;139(11):e133-e142. doi: 10.1016/j.jid.2019.08.437.
6
Personalized medicine-concepts, technologies, and applications in inflammatory skin diseases.个性化医疗——炎症性皮肤病中的概念、技术及应用
APMIS. 2019 May;127(5):386-424. doi: 10.1111/apm.12934.
7
2D Visualization of the Psoriasis Transcriptome Fails to Support the Existence of Dual-Secreting IL-17A/IL-22 Th17 T Cells.银屑病转录组的 2D 可视化无法支持双分泌 IL-17A/IL-22 Th17 T 细胞的存在。
Front Immunol. 2019 Apr 4;10:589. doi: 10.3389/fimmu.2019.00589. eCollection 2019.
8
Psoriasis pathogenesis and the development of novel targeted immune therapies.银屑病的发病机制与新型靶向免疫疗法的发展
J Allergy Clin Immunol. 2017 Sep;140(3):645-653. doi: 10.1016/j.jaci.2017.07.004.
9
Establishing an Academic-Industrial Stratified Medicine Consortium: Psoriasis Stratification to Optimize Relevant Therapy.建立学术-产业分层医学联盟：银屑病分层以优化相关治疗
J Invest Dermatol. 2015 Dec;135(12):2903-2907. doi: 10.1038/jid.2015.286.
10
The emerging role of IL-17 in the pathogenesis of psoriasis: preclinical and clinical findings.IL-17 在银屑病发病机制中的新作用：临床前和临床研究发现。
J Invest Dermatol. 2013 Jan;133(1):17-26. doi: 10.1038/jid.2012.194. Epub 2012 Jun 7.
本文引用的文献
1
Epidermal T lymphocytes and HLA-DR expression in psoriasis.银屑病中的表皮T淋巴细胞与HLA - DR表达
Br J Dermatol. 1984 May;110(5):555-64. doi: 10.1111/j.1365-2133.1984.tb04678.x.
2
T-cell subpopulations in the blood and skin of patients with psoriasis.
Br J Dermatol. 1984 Jan;110(1):37-44. doi: 10.1111/j.1365-2133.1984.tb07309.x.
Zotero 插件